Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY OF THE CELL
Volume 22, Issue 19, Pages 3725-3733
Publisher
American Society for Cell Biology (ASCB)
Online
2011-08-11
DOI
10.1091/mbc.e11-04-0300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions
- (2011) Chunling Yi et al. CANCER CELL
- The Adaptor Protein AMOT Promotes the Proliferation of Mammary Epithelial Cells via the Prolonged Activation of the Extracellular Signal-Regulated Kinases
- (2011) W. P. Ranahan et al. CANCER RESEARCH
- Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
- (2011) B. Zhao et al. GENES & DEVELOPMENT
- Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
- (2011) Siew Wee Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases
- (2011) Ling Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling
- (2010) Tsutomu Oka et al. BIOCHEMICAL JOURNAL
- Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway
- (2010) Meghna Das Thakur et al. CURRENT BIOLOGY
- Hippo signaling: growth control and beyond
- (2010) G. Halder et al. DEVELOPMENT
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
- (2010) Wenqi Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Angiomotin-Like Protein 1 Controls Endothelial Polarity and Junction Stability During Sprouting Angiogenesis
- (2009) Yujuan Zheng et al. CIRCULATION RESEARCH
- Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases
- (2009) Yijun Bao et al. GENES TO CELLS
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
- (2009) Jianmin Zhang et al. NATURE CELL BIOLOGY
- Human angiomotin-like 1 associates with an angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeleton
- (2009) Valérie Gagné et al. CELL MOTILITY AND THE CYTOSKELETON
- Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway
- (2008) J. Zhang et al. CANCER RESEARCH
- MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation
- (2008) Maria Praskova et al. CURRENT BIOLOGY
- The Hippo–YAP pathway: new connections between regulation of organ size and cancer
- (2008) Bin Zhao et al. CURRENT OPINION IN CELL BIOLOGY
- Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
- (2008) Tsutomu Oka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway
- (2008) Q.-Y. Lei et al. MOLECULAR AND CELLULAR BIOLOGY
- Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1
- (2008) S Hirabayashi et al. ONCOGENE
- Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells
- (2007) Mira Ernkvist et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now